Is Indo-MIM IPO Good or Bad – Detailed Review


00:00 / 00:00
Summary:
| ||
Indo-MIM Limited’s IPO is set to open its initial public offering from July 23, 2026, to July 27, 2026. When considering applying for this IPO, potential investors might have questions about whether the Indo-MIM IPO is a good investment and if it's worth subscribing to.
This article provides a comprehensive analysis of Indo-MIM's IPO, covering its business operations and a fundamental analysis of its RHP to help you make an informed investment decision.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Indo-MIM IPO Review
Indo-MIM Limited IPO is open for subscription from July 23, 2026, to July 27, 2026, with listing expected on July 30, 2026, on NSE and BSE.
The company operates an advanced manufacturing setup consisting of 15 core manufacturing facilities (six in India across Bengaluru, Tirupati, and Sriperumbudur, six in the USA, two in the UK, and one in Mexico), along with six support facilities and five warehouses. The company originally commenced operations under the name AF Technologies India Private Limited in 1996.
The company provides a comprehensive range of custom precision components, tooling, and surface treatment solutions. Through its material subsidiaries, including Indo-MIM Inc. (USA), Triax Industries, LLC (USA), Conway Marsh Garrett Technologies Limited (UK), Phoenix DeVentures II Inc. (USA), and INDO-MIM Arms Components Private Limited (India) and its step-down subsidiary Indo-MIM México, it has expanded its product offerings into investment casting, medical device design, and 3D metal printing, serving a diverse global B2B clientele.
As of the fiscal year ended March 31, 2026, the company reported a consolidated revenue from operations of Rs 4,192.99 crore, maintaining its position as the world's largest manufacturer of MIM precision components with a global market share of 6.8% in Calendar Year 2025.
The company’s operations are globally diversified, with export sales to 55 countries accounting for 77.20% of its total revenue from operations in FY26, while domestic sales within India accounted for the remaining 22.80%.
Its revenue from operations stood at Rs 2,870.40 crore in FY24 (consolidated restated), grew to Rs 3,329.58 crore in FY25 (consolidated), and reached Rs 4,192.99 crore in FY26 (consolidated).
For the year ended March 31, 2026, the company reported a Profit After Tax (PAT) of Rs 533.54 crore. This follows a net profit of Rs 423.73 crore in FY25 and Rs 283.73 crore in FY24, representing solid profitability growth.
The company maintains a strong consolidated EBITDA margin of 25.54% in FY26, 28.01% in FY25, and 25.90% in FY24.
Key strengths include its global leadership in MIM technology, end-to-end "concept to delivery" design and tooling capabilities, long-standing relationships with tier-1 Indian and global OEMs across five core sectors, robust in-house material formulation and backward integration, and healthy financial returns with a Return on Net Worth (RoNW) of 21.26% in FY26 and 19.94% in FY25.
Primary risks include customer concentration (top 10 customers contributed 38.41% of operational revenues in FY26), raw material price volatility due to sourcing inputs without long-term supply agreements, foreign exchange rate risk with 77.20% of operational revenue derived from exports, and potential financial exposures from ongoing tax and regulatory litigations.
The book-built issue consists of a Fresh Issue of up to Rs 500 crore and an Offer for Sale of up to Rs 3,311 crore, which will be received by the Selling Shareholders.
Shares are priced in the Indo-MIM IPO price band of Rs 461 to Rs 485 per share, with a minimum lot size of 30 shares.
Company Overview of Indo-MIM IPO
Indo-MIM builds complex, high-precision metal components that global OEMs buy to assemble into critical end-products.
They manufacture over 9,000 types of precision engineering components using specialized Metal Injection Molding (MIM), investment casting, precision CNC machining, ceramic injection molding, and 3D printing technologies.
Instead of making standalone simple parts, Indo-MIM offers complete custom mold design, tooling, powder compounding, injection molding, debinding, sintering, and advanced surface treatment.
Their automated setups allow B2B clients to integrate complex net-shape components directly into their assembly lines without requiring costly secondary machining or manual assembly.
OEMs then use Indo-MIM’s precision-engineered parts to manufacture automobiles, defence firearms, surgical instruments, consumer electronics, and aerospace systems worldwide.
Indo-MIM Business Segments
The company serves its B2B clients primarily through circular looms and tape extrusion lines, supplemented by other downstream equipment and spare parts:
Revenue Segment | % of Revenue (Year Ended March 31, 2026) |
Automotive Products Group (APG) | 24.61% |
Defence Products Group (DPG) | 18.69% |
Medical Products Group (MPG) | 18.08% |
Aerospace Products Group (Aerospace) | 11.96% |
Consumer Products Group (CPG) | 10.80% |
Others (Powder Sales, Tools, Traded Goods, Scrap) | 15.86% |
Total Revenue from Operations | 100.00% |
Company’s Management
The company is led by technically qualified promoters with extensive industry experience.
The Board is headed by Krishna Chivukula (Chairman and Managing Director), supported by Executive Director Krishna Chivukula Jr. (Whole-time Director and Chief Executive Officer) and Non-Executive Directors Jagadamba Chandrasekhar and Raj Chivukula.
The financial, administrative, and legal operations are overseen by Parasuraman Balasubramanian (Vice President – Finance and Chief Financial Officer) and Santosh Kumar Dash (Company Secretary and Compliance Officer).
Industry Overview of Indo-MIM IPO
Indo-MIM Limited operates within the global precision component manufacturing, metal injection moulding (MIM), investment casting, and 3D metal printing industries.
This sector is witnessing strong growth driven by increasing demand for lightweight, high-strength, complex components in automotive electrification, advanced medical devices, defence modernizations, and aerospace applications.
Market Metric | Current / Base Value | Projected / Target Value | Growth Rate (CAGR) / Market Share | Timeline |
Global Metal Injection Molding (MIM) Market | USD 4.0 Billion | USD 6.2 Billion | 9.20% | CY2025 to CY2030 |
Despite this growth potential, the industry faces structural constraints, including high tooling development costs, strict raw material feedstock purity standards, and lengthy OEM qualification cycles.
Industry statistics are sourced from the Indo-MIM Limited Red Herring Prospectus (RHP) dated July 17, 2026.
Financial Overview of Indo-MIM IPO
Particulars | Year Ended Mar 31, 2026 (Rs Crore) | Year Ended Mar 31, 2025 (Rs Crore) | Year Ended Mar 31, 2024 (Rs Crore) |
Revenue from Operations | 4,192.99 | 3,329.58 | 2,870.40 |
EBITDA Margin | 25.54% | 28.01% | 25.90% |
Profit After Tax (PAT) | 533.54 | 423.73 | 283.73 |
Return on Net Worth (RoNW) | 21.26% | 19.94% | 14.01% |
Return on Capital Employed (RoCE) | 26.60% | 23.51% | 19.59% |
Debt to Net Worth Ratio | 0.39x | 0.57x | 0.53x |
Note: Calculated on a restated and consolidated basis in accordance with Ind AS.
Revenue from Operations: Consolidated revenue from operations grew significantly by 25.93% from Rs 3,329.58 crore in FY25 to Rs 4,192.99 crore in FY26, driven by higher product volumes across the automotive, medical, and aerospace sectors.
EBITDA Margin: Core operating profitability remained strong at 25.54% in FY26, 28.01% in FY25, and 25.90% in FY24, supported by high operational asset utilization and in-house manufacturing of feedstock and tooling.
Profit After Tax (PAT): Bottom-line net profit grew by 25.91% to Rs 533.54 crore in FY26 from Rs 423.73 crore in FY25, indicating expanding operational scale.
Return on Net Worth (RoNW): Reflecting strong capital efficiency, RoNW increased to 21.26% in FY26 from 19.94% in FY25 and 14.01% in FY24.
Return on Capital Employed (RoCE): RoCE expanded to 26.60% in FY26 from 23.51% in FY25 and 19.59% in FY24, highlighting healthy returns on capital investments.
Debt to Equity Ratio: The leverage ratio stood at a comfortable 0.39x as of March 31, 2026, down from 0.57x in FY25, reflecting solid internal accruals and balance sheet strength.
Financial figures are sourced from the Indo-MIM Limited Red Herring Prospectus (RHP) dated July 17, 2026.
Strengths and Risks of Indo-MIM IPO
Let's examine the strengths and weaknesses to determine whether the Indo-MIM IPO is good or bad for investors.
Strengths
Global MIM Leadership: World's largest manufacturer of precision components using MIM technology with a 6.8% global market share in CY2025, maintaining leadership for six consecutive years.
Dual-Shore Manufacturing Footprint: Operates 15 manufacturing facilities across India, the United States, the United Kingdom, and Mexico, offering global supply security and nearshoring options to international OEMs.
Diversified Sector Portfolio: Serves over 1,100 clients across five distinct industries (automotive, defence, medical devices, consumer products, and aerospace).
High Customer Stickiness: High rate of repeat orders (repeat customers contributed 91.60% of operational revenue in FY26) due to long qualification timelines (2-3 years) and high custom tooling costs.
Advanced Technology Integration: Comprehensive adoption of automation with 436 deployment-ready robots and 476 IoT-enabled machines as of FY26.
Risks
Customer Concentration: Top 10 customers accounted for 38.41% of operational revenues in FY26, exposing the company to order fluctuations from key accounts.
Absence of Long-Term Binding Agreements: Customers generally place orders on an open/discreet purchase order basis without firm long-term volume commitments.
Raw Material and Import Dependency: In FY26, 60.95% of raw material purchases were imported; raw materials are bought on short-term purchase orders, exposing margins to price and supply chain volatility.
Foreign Exchange Volatility: Export sales represented 77.20% of operational revenue in FY26, exposing performance to currency fluctuations (primarily USD and Euro).
Lengthy OEM Qualification Lead Times: The selection and qualification process for new OEM parts takes 2 to 3 years, limiting rapid short-term revenue ramp-ups.
Strategies of Indo-MIM IPO
Customer Acquisition & Wallet Share: Leverage long-standing relationships with global OEMs to expand product offerings, deepen account penetration, and acquire new international clients.
Technology-Driven Portfolio Expansion: Capitalize on sector tailwinds across automotive, aerospace, medical, and defense by deploying 3D metal printing, investment casting, and ceramic molding.
Technological Leadership & R&D: Enhance in-house engineering capabilities, advance material formulations, and develop novel tooling solutions to maintain industry leadership and innovation momentum.
Operational Efficiency & Cost Rationalization: Drive shop-floor productivity and cost optimization through expanded factory automation, IoT machine integration, and strategic backward powder integration.
Global Footprint Expansion: Strengthen direct distribution and export reach across North America, Europe, and Asia through targeted organic extensions and selective strategic acquisitions.
Indo-MIM IPO vs. Peers
According to the RHP, there are no direct listed pure-play MIM peers in India. However, the company compares its operational metrics against its primary global listed peer, Jiangsu Gian Technology Co, Ltd (listed on the Shenzhen Stock Exchange):
Revenue Scale: Indo-MIM generated Rs 4,192.99 crore (USD 465 million) in FY26, compared to Jiangsu Gian's Rs 4,060.51 crore (USD 429 million) in CY2025.
Operating EBITDA Margins: Indo-MIM delivers higher core operational profitability with an EBITDA margin of 25.54% in FY26, compared to Jiangsu Gian's 14.74% in CY2025.
Net Profit Margin: Indo-MIM recorded a PAT margin of 12.72% in FY26, significantly higher than Jiangsu Gian's 2.32% in CY2025.
Return on Net Worth (RoNW): Indo-MIM recorded an RoNW of 21.26% in FY26 versus Jiangsu Gian's 3.10% in CY2025.
Objectives of Indo-MIM IPO
The total issue size is worth Rs 3,811 crore, out of which Rs 3,311 crore is marked as offer for sale and the remaining Rs 499 crore is marked as a fresh issue.
The funds raised through the fresh issue through an IPO will be used for the following objectives.
Prepayment or Repayment of Outstanding Borrowings by the company (Rs 400 crore)
The remaining funds will be used for General Corporate Purposes.
Indo-MIM IPO Details
IPO Dates
Indo-MIM IPO will be open for subscription from July 23, 2026, to July 27, 2026. The allotment of shares to investors will take place on July 28, 2026, and the company is expected to be listed on the NSE and BSE on July 30, 2026.
IPO Issue Price
Indo-MIM is offering its shares in the price band of Rs 461 to Rs 485 per share. This means you would require an investment of Rs 14,550 per lot (30 shares) if you are bidding for the IPO at the upper price band.
IPO Size
Indo-MIM is launching a total issue of Rs 3,811 crore, out of which the offer for sale is worth Rs 3,311 crore and the fresh issue is worth Rs 499 crore.
IPO Allotment Status
Investors who applied for the IPO can check their IPO allotment status on July 28, 2026, through the registrar's website, MUFG Intime India Private Limited, BSE, NSE, or through their stockbroker platform.
IPO Listing Date
The shares of Indo-MIM are expected to be listed on the NSE and BSE on July 30, 2026.
IPO Application Link
Open demat account with Rupeezy today and enjoy a seamless experience when applying for the IPO. With an easy-to-use platform, Rupeezy makes the IPO application process quick and hassle-free.
Important IPO Details | |
Bidding Date | July 23, 2026 to July 27, 2026 |
Allotment Date | July 28, 2026 |
Listing Date | July 30, 2026 |
Issue Price | Rs 461 to Rs 485 per share |
Lot Size | 30 Shares |
The content on this blog is for educational purposes only and should not be considered investment advice. While we strive for accuracy, some information may contain errors or delays in updates.
Mentions of stocks or investment products are solely for informational purposes and do not constitute recommendations. Investors should conduct their own research before making any decisions.
Investing in financial markets are subject to market risks, and past performance does not guarantee future results. It is advisable to consult a qualified financial professional, review official documents, and verify information independently before making investment decisions.
Disclaimer
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Rupeezy (SEBI RA Registration: INH000013332) provides this content for informational purposes; any securities quoted are for educational display and not as a recommendation. All charts and graphs are based on independent research and reliable sources for the period mentioned within the specific data set. Sometimes we take graphs from external sources. This communication does not promise or assure any fixed, guaranteed, or indicative returns to any client. For our complete registered office address, Member ID, and full SEBI registration details, please refer to our official website.

All Category





